← Back to Search

Telehealth Exercise to Music for Huntington's Disease (MtI Trial)

N/A
Recruiting
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Above the age of 21 years
Confirmed diagnosis of a degenerative neurologic disorder such as HD, PD, mild dementia or mild cognitive impairment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if a movement and music exercise program delivered over video chat is feasible and safe for people with neurodegenerative diseases and their caregivers. A secondary goal is to see if the program improves balance, cognition, mobility, and quality of life.

Who is the study for?
This trial is for adults over 21 with neurodegenerative diseases like Huntington's, Parkinson's, or mild cognitive impairments. Participants need a caregiver to assist them, stable medication use, and internet access for the online program. Those already in another trial or doing regular exercise three times a week can't join.
What is being tested?
The study tests if exercising to music through an online telehealth service is doable and safe for people with neurodegenerative diseases and their caregivers. It also looks at whether this improves balance, thinking skills, mobility, and life quality.
What are the potential side effects?
Since the intervention involves physical activity set to music via telehealth services rather than medication or invasive procedures, side effects may include typical exercise-related issues such as muscle soreness or fatigue.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 21 years old.
Select...
I have been diagnosed with a condition like Huntington's, Parkinson's, or mild dementia.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in 12-item Self-Report World Health Organization Disability Assessment Schedule (WHODAS) 2.0 questionnaire from baseline
Change in 12-item Self-Report World Health Organization Disability Assessment Schedule (WHODAS) 2.0 questionnaire from baseline - TELEHEALTH
Change in 4 stage balance test from baseline: feet in tandem from baseline
+16 more
Secondary study objectives
Change in Symbol Digit Modality Test (SDMT) from baseline
Change in Unified Huntington's Disease Rating Scale (UHDRS) Functional Assessment scale from baseline
Change in Unified Huntington's Disease Rating Scale (UHDRS) Independence scale from baseline
+2 more
Other study objectives
Open-ended questionnaire

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Individuals with HDExperimental Treatment1 Intervention
Participants with a confirmed diagnosis of Huntington's disease
Group II: Care PartnersExperimental Treatment1 Intervention
Participants' care partners

Find a Location

Who is running the clinical trial?

Huntington's Disease Society of AmericaUNKNOWN
1 Previous Clinical Trials
15 Total Patients Enrolled
Ohio State UniversityLead Sponsor
866 Previous Clinical Trials
655,064 Total Patients Enrolled

Media Library

Movement to Music Clinical Trial Eligibility Overview. Trial Name: NCT05270681 — N/A
Huntington's Disease Research Study Groups: Individuals with HD, Care Partners
Huntington's Disease Clinical Trial 2023: Movement to Music Highlights & Side Effects. Trial Name: NCT05270681 — N/A
Movement to Music 2023 Treatment Timeline for Medical Study. Trial Name: NCT05270681 — N/A
~15 spots leftby Nov 2025